Navigation Links
Genoptix Announces Participation at the Barclays Capital 2010 Global Healthcare Conference
Date:3/15/2010

CARLSBAD, Calif., March 15 /PRNewswire-FirstCall/ -- Genoptix, Inc. ( GXDX), a specialized laboratory services provider, today announced the Company's participation at the Barclays Capital 2010 Global Healthcare Conference at the Loews Miami Hotel in Miami, Fla. to be held March 23-24, 2010.  

Doug Schuling, EVP and CFO of Genoptix, will present at the conference on Tuesday, March 23, 2010 beginning at approximately 2:30 p.m. EDT, when he will provide an overview of the Company's specialized diagnostic laboratory services business, growth strategies and financial performance.

The presentation is expected to last approximately 25 minutes and will be web cast live through the "Investors" section of the Genoptix website at www.genoptix.com. Those who would like to listen to the presentation should go to this site at least 15 minutes prior to the event to register, download and install any necessary software. An audio replay will be available for 30 days following the initial presentation web cast.

About Genoptix, Inc.

Genoptix is a leading specialized laboratory service provider focused on delivering personalized and comprehensive diagnostic services to its physician customers, community-based hematologists and oncologists. On the forefront of personalized diagnostic services, Genoptix's highly trained group of hematopathologists utilize sophisticated technology to provide integrated testing and actionable diagnostic reports. Its diagnostic services are designed to optimize the care of patients suffering from hematomalignancies, or cancers of the blood and bone marrow, including leukemia and lymphoma. Founded in 1999, Genoptix is a member of the Nasdaq Select Global Market and the S&P SmallCap 600 Index and is headquartered in Carlsbad, California. For more information, please visit www.genoptix.com.

Forward-Looking Statements

This press release contains forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in the forward-looking statements. Genoptix disclaims, however, any intent or obligation to update these forward-looking statements.

SOURCE Genoptix, Inc.

Back to top

RELATED LINKS
http://www.genoptix.com

'/>"/>

SOURCE Genoptix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Genoptix Reports Continued Strong Growth for the Second Quarter and First Half of 2009
2. Genoptix, Inc. to Announce Second Quarter 2009 Financial Results
3. Genoptix Announces Participation at the 29th Annual William Blair Growth Stock Conference
4. Genoptix Announces Participation at the Bank of America and Merrill Lynch 2009 Annual Health Care Conference
5. Genoptix Reports Strong Growth for the First Quarter of 2009
6. Genoptix, Inc. to Announce First Quarter 2009 Financial Results
7. Genoptix Announces Participation at the Cowen and Company 29th Annual Health Care Conference
8. Genoptix Announces Participation at Barclays Capital Global Healthcare Conference
9. Genoptix Reports Strong Full-Year Financial Results for 2008 and Raises Guidance for 2009
10. Genoptix Announces Participation at the RBC Capital Markets 2008 Healthcare Conference
11. Genoptix Reports Strong Financial Results for the Third Quarter and Raises Guidance for Full-Year 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... Newark, NJ (PRWEB) , ... April 28, 2017 , ... ... Poor’s has affirmed the company’s credit rating of “A” and its outlook as “stable.” ... downgraded if capital reserves, which have fallen in recent years, dip below “capital adequacy” ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. announced today a ... the Northeast U.S. , GlycoMark is the only clinically available blood test ... a clinically proven one- to two-week measure of hyperglycemic excursions, often related to ...
(Date:4/28/2017)... , ... April 28, 2017 , ... ... Replace tubes . These lamps offer an instant energy-saving solution for F32T8 fluorescent ... rewire fixtures or disconnect ballasts. These 50,000 hour rated lamps utilize the existing ...
(Date:4/28/2017)... , ... April 28, 2017 , ... ... that Aditya Patel M.D. has joined the revolutionary endoscopic practice under Dr. Datta. ... certification in Interventional Pain Medicine. The patented, revolutionary eDiscSculpt Technique created and used ...
(Date:4/28/2017)... ... , ... The Texas Cord Blood Bank (TCBB), a program of nonprofit biomedical ... Women’s Hospital at Renaissance in Edinburg for their outstanding efforts in collecting umbilical cord ... donate. , “Women’s Hospital at Renaissance has been a collection partner for the ...
Breaking Medicine News(10 mins):
(Date:4/26/2017)... Phoenix Marketing Solutions ( Phoenix ) ... mission of transforming science into clinical practice. During a time ... innovative approach supports the life sciences industry by ... in science and medicine — which ultimately improves lives. ... 2002 by Tracy Doyle and Angela Fiordilino ...
(Date:4/20/2017)... -- Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical ... and Gynecology markets with innovative and proprietary products, ... Company as Senior Vice President, Marketing & Business ... will report directly to Darin Hammers , ... delighted that Ash has joined the Cogentix team," ...
(Date:4/20/2017)... DUBLIN , April 20, 2017 Research ... Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market and ... to their offering. ... market for drug delivery technologies will rise from USD 20 Billion ... Global Drug Delivery Technologies - Innovation Driven by Rapidly ...
Breaking Medicine Technology: